Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 11Active not recruiting 4Withdrawn 2Suspended 1Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 55Prostatic Neoplasms 46Glioblastoma 28Brain Neoplasms 25Neoplasms 23Glioma 21Carcinoma, Non-Small-Cell Lung 19Lung Neoplasms 18Carcinoma, Hepatocellular 14Gliosarcoma 13Colorectal Neoplasms 12Uterine Cervical Neoplasms 11Neoplasm Metastasis 11Rectal Neoplasms 10Lymphoma, Non-Hodgkin 10Oligodendroglioma 9Melanoma 9Central Nervous System Neoplasms 9Astrocytoma 9Lymphoma 8Head and Neck Neoplasms 8Esophageal Neoplasms 8Colonic Neoplasms 8Ependymoma 7Squamous Cell Carcinoma of Head and Neck 6Pancreatic Neoplasms 6Lymphoma, Large B-Cell, Diffuse 6Carcinoma, Renal Cell 6Breast Neoplasms, Male 6Ovarian Neoplasms 5

Interventions

Carboplatin 27Paclitaxel 23Cisplatin 22Gemcitabine 17pembrolizumab 15Fluorouracil 9Pemetrexed 8Everolimus 8Docetaxel 8Cetuximab 8Radiotherapy, Intensity-Modulated 7Radiotherapy 7130-nm albumin-bound paclitaxel 7Sorafenib 6Nivolumab 6Bevacizumab 6Axitinib 6epothilone B 5Sunitinib 5Radiation 5Panitumumab 5Cyclophosphamide 5trebananib 4reolysin 4padeliporfin 4lenvatinib 4Irinotecan 4Gefitinib 4vosaroxin 3volociximab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma × Magnetic Resonance Spectroscopy × Clear all
NCT00599755 2018-01-16

Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)

Merck Sharp & Dohme LLC

Phase 1 Completed
68 enrolled 12 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡